Clinical trials
Completed Phase 3 trials in Serbia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
598 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 9 |
| 2005 | 12 |
| 2006 | 22 |
| 2007 | 31 |
| 2008 | 36 |
| 2009 | 23 |
| 2010 | 25 |
| 2011 | 50 |
| 2012 | 36 |
| 2013 | 33 |
| 2014 | 36 |
| 2015 | 45 |
| 2016 | 53 |
| 2017 | 32 |
| 2018 | 35 |
| 2019 | 27 |
| 2020 | 28 |
| 2021 | 21 |
| 2022 | 10 |
| 2023 | 16 |
| 2024 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 598 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 44 |
| Hoffmann-La Roche | 37 |
| Pfizer | 27 |
| AbbVie | 18 |
| Boehringer Ingelheim | 18 |
| Sanofi | 18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 15 |
| Takeda | 14 |
| Janssen Research & Development, LLC | 13 |
| Novartis Pharmaceuticals | 13 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 37 |
| Arthritis, Rheumatoid | 31 |
| Schizophrenia | 30 |
| Colitis, Ulcerative | 25 |
| Diabetes Mellitus | 24 |
| Carcinoma, Non-Small-Cell Lung | 21 |
| Crohn Disease | 21 |
| Multiple Sclerosis | 21 |
| Major Depressive Disorder | 16 |
| Breast Neoplasms | 15 |
Trials
Showing 1 to 25 of 598. Each trial links to its page on Pharma Observatory.
498 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.